Get started

CARE

$XLV:$KRE: Deflation winners and losersWe're seeing value health care ($XLV) show a lot of relative strength against other sectors as the dollar has been pushing. ($KRE) is often tied to growth when compared to it's bigger brother ($XLF) and eventhough financials do tend to benefit from rising rates, this has been much more of a hard landing and the financial rotation many expect may not come to pass, instead look for $XLV to continue soaking up 2022 when compared to other sectors.
AMEX:XLVLong
by Fox_Technicals
$MRK: Vaccine KrptoniteInvestors should continue to watch Merck and how it plays out here at the 80 level as their COVID drug treatment is pending approval. I believe the market is absolutely sleeping on the significance of this drug and the kind of impact it will have. A treatment is an absolute game changer provided the politics of COVID do not disrupt innovation, transparency and competition in the market. If Merck's drug is effective at treating COVID this will be disastrous to companies like MRNA, JNJ, DVAX, PFE and NVAX. Currently, we're still sitting at less than a 60% fully vaccinated population, the tightest labor supply in history and a work force petitioning vaccine mandates as was witnessed with Boeing workers in Seattle. This will force lawmakers hands to suspend vaccine mandates indefinitely crashing demand for vaccines in the future. The US population has made their stance and vaccine persuasion will only have a diminishing effect from here on out, so the only option is the option that works for everyone in order to minimize division in the country.
NYSE:MRKLong
by Fox_Technicals
A good opportunity in a situation of light overboughtMy advisor Marketmiracle gave an input signal for the stock ALIGN TECHNOLOGY $ALGN at a price of 588.09 usd with a target of 634.1391 with a possible profit of 7.83% According to the chart the stock seems to actually want to continue to rise despite the laggera situation of over-bought, the rest less than a month ago has delivered excellent results with a surprise of 23% compared to the estimates of analysts. Moreover according to some sites of fundamental analysis to which I refer the price of the Stock seems to be underestimated of approximately 7% regarding the just value. All this makes me think that with good odds the title will rise, in the next week as soon as I have liquidity I will take positions. This idea is based on a signal generated by the advisor Marketmiracle, down on this page you will find the link to the page of signals of the advisor that you can see for free without any cost or registration
NASDAQ:ALGNLong
by MarketMiracleAdvisor
CARE, A great opportunity and currently my favorite stock. A little bit about CARE: Carter Bank & Trust provides a range of retail and commercial banking products and services in Virginia and North Carolina. The company also offers loans, such as secured and unsecured commercial loans; secured and unsecured consumer loans for financing automobiles, home improvements, education, and personal investments; real estate construction and acquisition loans; fixed and variable rate mortgage loans; and insurance products. In addition, it provides safe deposit boxes, direct deposit of payroll and social security checks, and automated drafts for various accounts. As of May 18, 2020, the company operated 99 branches. Carter Bank & Trust was founded in 1974 and is headquartered in Martinsville, Virginia. Reasoning behind why it is my favorite at this time : Care is my favorite stock on the market right now and I see it as a stock that could easily grow by 100%+ the following months but also has the benefit of being a very stable and safe investment that somehow has not climbed up like the rest of the market after the march crash. I can see that there are some volume has been very low which explains why the stock has not moved up (lack of demand/volume). I believe this is because traders are largely unaware of the stocks existence, I think CARE is an undiscovered gem. This presents and huge opportunity for traders. Not only is CARE extremely undervalued, but it’s price has mostly moved horizontally since March 18th. Through this time CARE has maintained its support trend line perfectly. Recent earnings report out on July 24th beat by 87% higher than expected (estimate was +0.09 eps , actually earned 0.17+) , yet the stock was still largely unnoticed. Amazing. Furthermore on July 31st CARE announced today that beginning July 28, 2020, certain directors and executive officers of Carter Bank & Trust have entered into stock purchase plans for the future purchase of the Bank's common stock, which is certainly bullish but also has seemingly been missed by traders. Analysts 12 Month Price Target: Wall Street analysts have issued ratings and price targets for Carter Bank and Trust in the last 12 months. Their average twelve-month price target is $10.50, predicting that the stock has a possible upside of 44.83%. The high price target for CARE is $10.50 and the low price target for CARE is $10.50. I personally would not be surprised to see some volatile price action come in very soon with CARE . At this time , support is around $7 and resistance is near $10.50. This Is a long term hold for me , solid growth company with very low debt, lots of cash, good future outlook, and a high level of sustainability. Here are some important fundamental metrics (as of August 20th 2020): Ma Income: 26.40 Market Cap: 190.88M Book per share: 18.00 (Price per book: 0.40) Employees: 992 Short Term Debt/Equity: 0.00 Long Term Debt/Equity: 0.00 Avg Volume: 96.92K EPS this Year: 462.30% EPS next Year: 0.31 EPS (ttm): 1.01 P/E: 7.21 Who is holding this stock : Breakdown: 14.45% % of Shares Held by All Insider 32.97% % of Shares Held by Institutions 38.53% % of Float Held by Institutions (110 Institutions Holding Shares) 52.98% held by retail traders. I Like to see stocks that have a decent institution holding percentage because it can help to prevent unwarranted sell off of a stock and price tends to be more stable which we have clearly seen as CARE has continued to hold support so well , I think that CARE has a healthy level of institution/insider holders .
NASDAQ:CARELong
by NAK1987
10
Corvel: An Insurance Broker with Upside in 2020Corvel is an insurance broker that focuses on managed care that continues to post good EPS, ROE, Income, Revenue and Diluted EPS. Technically speaking the fallen triangle has already happened and that will send the stock soaring into record highs sooner than later. In the market, you want to always check for fallen descending triangles which in-turn form consolidations to an eventual cup then breakout. This represents one of the most bullish patterns in the entire stock market that people consistently overlook. TP: 130+ by end of 2020. - zSplit
NASDAQ:CRVLLong
by PaulDeep19131